- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
U2AF65 antibody targets U2 small nuclear RNA auxiliary factor 2, encoded by the U2AF2 gene. U2AF65 is a nuclear RNA-binding protein that functions as a core component of the pre-mRNA splicing machinery. It plays a critical role in early spliceosome assembly by recognizing and binding the polypyrimidine tract at the 3-prime splice site of introns. Through this activity, U2AF65 facilitates recruitment of additional splicing factors and ensures accurate intron removal during gene expression.
Functionally, U2AF65 works as a heterodimer with U2AF35, forming the U2AF complex that defines splice site selection and exon-intron boundaries. By stabilizing interactions between pre-mRNA and the U2 small nuclear ribonucleoprotein, U2AF65 supports precise and efficient spliceosome assembly. This process is essential for generating correctly spliced mRNA transcripts and maintaining proteome diversity. A U2AF65 antibody supports studies focused on RNA splicing regulation and post-transcriptional gene control.
U2AF2 is broadly expressed in eukaryotic cells, reflecting the universal requirement for accurate pre-mRNA splicing. Expression is particularly relevant in highly transcriptionally active cells, where dynamic regulation of alternative splicing is required to adapt gene expression programs. U2AF65 interacts with numerous splicing regulators and RNA-binding proteins, positioning it as a central hub in the control of constitutive and alternative splicing events.
From a disease-relevance perspective, dysregulation of U2AF65-mediated splicing has been implicated in cancer and genetic disease. Altered expression or mutation of splicing factors can lead to aberrant exon usage and production of dysfunctional protein isoforms. U2AF2 has been studied in the context of tumorigenesis, where changes in splicing patterns contribute to altered cell growth, survival, and differentiation. These associations make U2AF65 an important target for investigating splicing-related mechanisms of disease.
At the molecular level, U2AF65 contains RNA recognition motifs that enable specific binding to uridine-rich sequences within pre-mRNA. Post-translational modifications and interactions with partner proteins can modulate its splicing activity and influence its behavior in biochemical assays without implying changes in primary sequence. A U2AF65 antibody supports research applications focused on spliceosome function, RNA processing, and disease-associated alterations in mRNA splicing, with NSJ Bioreagents providing reagents intended for research use.
Optimal dilution of the U2AF65 antibody should be determined by the researcher.
Recombinant human protein (amino acids M238-H470) was used as the immunogen for the U2AF65 antibody.
After reconstitution, the U2AF65 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.